September 4, 2015

AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.

August 26, 2015

Based on prescriptions filled, taking 75 mg to 150 mg of aspirin continuously for five years or longer was associated with a 27% reduced risk for colorectal cancer.

August 20, 2015

The top four best-selling internal analgesic brands — Advil, Aleve, Tylenol and Bayer — generate more than 40% of the overall $3.3 billion in internal analgesic tablet sales, according to IRI figures. But it’s the smaller niche external analgesic brands that are contributing a lot of incremental sales to the pain relief category.

July 15, 2015

Pfizer and the Arthritis Foundation will work togeher on developing educational tools in support of arthritis. 

July 13, 2015

The Food and Drug Administration warns patients that prolonged use of NSAIDs could increase risk of heart attack or stroke. 

March 4, 2015

While the big four analgesic manufacturers — Bayer, Pfizer, McNeil and Novartis — command the lion’s share of retail ad support behind their mega analgesic brands, Prestige Brands and BedRock Brands are making headway promoting their niche pain relieving products.

February 24, 2015

An American Academy of Neurology study found that people who exhibit a resistance to aspirin may be more likely to have more severe strokes. 

December 16, 2014

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

December 10, 2014

Mylan on Wednesday launched its celecoxib capsules in 50-, 100-, 200- and 400-mg dosage strengths. The drug is one of the first available generic versions of Celebrex capsules from Pfizer.

December 8, 2014

The pros of giving healthy women regular low dose aspirin to stave off such serious illness as cancer and heart disease are outweighed by the cons, suggests a large study published online last week in the journal Heart.

December 2, 2014

Perrigo on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for diclofenac sodium topical solution 1.5% w/w.

November 18, 2014

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.

August 25, 2014

Pharmaceutical company Iroko announced today that a new version its anti-inflammatory drug Zorvolex had been approved by the Food and Drug Administration.

August 20, 2014

The lion’s share of the analgesics business may be in internal analgesics — sales of which totaled $3.6 billion, up 1.1% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI — but it’s alternative pain relievers that may represent the growth opportunity.

August 20, 2014

Researchers at the University of California, San Diego School of Medicine concluded that aspirin, in addition to preventing pain and inflammation, actually helps hasten the end of inflammation in a study published this week in the online early edition of PNAS.

August 20, 2014

GM Pharmaceuticals recently launched 8-oz. bottles of its liquid pain reliever, VanaPain, which includes 16 servings of its daytime pain reliever and eight servings of its nighttime pain reliever.

August 18, 2014

Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs, according to data published last week in Cancer Research, a journal of the American Association for Cancer Research.

June 2, 2014

Mylan announced on Monday that it has entered into a settlement and license agreement with Pfizer relating to Mylan's abbreviated new drug application filed with the U.S. Food and Drug Administration for celecoxib capsules in 50-mg, 100-mg, 200-mg and 400-mg strengths.

May 27, 2014

The May/June 2014 Skin & Itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of AmLactin Cerapeutic Restoring, Cetaphil RestoraDerm Skin Restoring, Olay Advanced Healing Intensive, Curél Intesive Healing, Nivea Extended Moisture, Aveeno 1% Hydrocortisone Anti-itch, Extra Strength Benadryl Itch Stopping and Corizone 10 Anti-itch Ultra Moisturing Creme Plus.

May 22, 2014

Prasco Labs on Thursday announced it has entered into a distribution and supply agreement with Recordati Rare Diseases for the rights to distribute ibuprofen lysine injection, the authorized generic version of NeoProfen (ibuprofen lysine).

April 14, 2014

Pfizer Consumer Healthcare on Monday teamed up with actor and active volunteer Josh Duhamel for the Advil Relief in Action campaign, which features the #ReliefinAction Pledge on Facebook and a Mobile Relief Center tour making approximately 100 stops throughout the country.

April 9, 2014

GM Pharmaceuticals recently announced the addition of 8-oz. bottles to its line of liquid pain relief VanaPain.

April 3, 2014

First Aid Shot Therapy on Wednesday announced the launch of First Aid Shot Therapy Upset Stomach.

March 31, 2014

Greenstone announced the introduction of Piroxicam capsules to its generic pharmaceutical product line. The drug is offered in dosage strengths of 10 mg and 20 mg, and is the generic equivalent to Feldene.